🔗 Permalink

Assignee profile:

BIOSURFACE ENGINEERING TECHNOLOGIES, INC.

City:

Rockville, Maryland

Country:

United States

Published Applications:

Last publication date:

2012-12-06

Patent Grants:

Last grant date:

2014-08-05

Top Inventors for applications by BIOSURFACE ENGINEERING TECHNOLOGIES, INC.

These are the the leading inventors for applications assigned to BIOSURFACE ENGINEERING TECHNOLOGIES, INC.:

Paul O. Zamora 16 Gaithersburg, MD United States
Xinhua Lin 11 Plainview, NY United States
Louis A. Pena 10 Poquott, NY United States
Kazuyuki Takahashi 5 Germantown, MD United States

John D. Glass 2 Shoreham, NY United States
Brent Lee Atkinson 2 Frederick, MD United States
Meng Chen 1 Silver Springs, MD United States
Sarah Campion 1 Danville, CA United States

Shigemasa Osaki 1 Sandy, UT United States
Ray Tsang 1 Salt Lake City, UT United States
Ting-Ting Hsieh 1 Midvale, UT United States
Paul Zamora 1 Gaithersburg, MD United States

Recent patent applications by BIOSURFACE ENGINEERING TECHNOLOGIES, INC.

BIOSURFACE ENGINEERING TECHNOLOGIES, INC. based in Rockville, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-12-06

US20120309694A1

Human necessities

Dual Chain Synthetic Heparin-Binding Growth Factor Analogs

#2 | 2011-12-15 ✅ Patent 8,796,212 granted on 2014-08-05

US20110305741A1

Chemistry; metallurgy

Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis

#3 | 2010-11-25 ✅ Patent 8,101,570 granted on 2012-01-24

US20100298218A1

Chemistry; metallurgy

Single branch heparin-binding growth factor analogs

#4 | 2010-10-26 ✅ Patent 7,820,172 granted on 2010-10-26

US11757242

Laminin-derived multi-domain peptides

#5 | 2010-10-21 ✅ Patent 8,163,717 granted on 2012-04-24

US20100267650A1

Human necessities

Dual chain synthetic heparin-binding growth factor analogs

#6 | 2010-04-20 ✅ Patent 7,700,563 granted on 2010-04-20

US10644703

Synthetic heparin-binding factor analogs

#7 | 2009-06-04

US20090143566A1

Chemistry; metallurgy

Growth Factor Analogs

#8 | 2009-04-30

US20090111743A1

Chemistry; metallurgy

Cysteine-branched heparin-binding growth factor analogs

#9 | 2008-12-23 ✅ Patent 7,468,210 granted on 2008-12-23

US10733208

Cross-linked heparin coatings and methods

#10 | 2008-09-18

US20080227696A1

Chemistry; metallurgy

Single branch heparin-binding growth factor analogs

#11 | 2008-08-19 ✅ Patent 7,414,028 granted on 2008-08-19

US11051292

Growth factor analogs

#12 | 2008-03-13 ✅ Patent 7,981,862 granted on 2011-07-19

US20080063622A1

Chemistry; metallurgy

Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis

#13 | 2007-11-20 ✅ Patent 7,297,343 granted on 2007-11-20

US10684022

Bioactive medical films

#14 | 2007-05-15 ✅ Patent 7,217,769 granted on 2007-05-15

US10893603

Medical device with plasma cross-linked hydrophilic coating

#15 | 2007-01-23 ✅ Patent 7,166,574 granted on 2007-01-23

US10224268

Synthetic heparin-binding growth factor analogs

#16 | 2006-09-14 ✅ Patent 7,671,012 granted on 2010-03-02

US20060205652A1

Human necessities

Formulations and methods for delivery of growth factor analogs

#17 | 2006-09-07 ✅ Patent 8,227,411 granted on 2012-07-24

US20060199764A1

Chemistry; metallurgy

FGF growth factor analogs

#18 | 2005-10-06 ✅ Patent 7,598,224 granted on 2009-10-06

US20050222394A1

Human necessities

Dual chain synthetic heparin-binding growth factor analogs

AssigneeID:

194817 ⎘